Clinical Trials Logo

Post Traumatic Seizures clinical trials

View clinical trials related to Post Traumatic Seizures.

Filter by:
  • None
  • Page 1

NCT ID: NCT04573803 Not yet recruiting - Clinical trials for Traumatic Brain Injury

Pharmacological Management of Seizures Post Traumatic Brain Injury

MAST
Start date: March 1, 2021
Phase: Phase 3
Study type: Interventional

The overall aim of the MAST trial is to define best practice in the use of anti-epileptic drugs (AEDs) for patients following a traumatic brain injury (TBI). The trial will consist of two parts. The first part aims to answer whether a shorter or a longer course of AEDs is better to prevent further seizures in patients who have started having seizures following TBI (MAST - duration). The second part aims to answer whether a 7-day course of either Phenytoin or Levetiracetam should be used for patients with a serious TBI to prevent seizures from starting (MAST- prophylaxis).